All filters
Slidesets
Drug-Induced Liver Injury and NASH -- Raúl Andrade, MD, PhD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
Cardiovascular Risk in NAFLD -- Jörn Schattenberg, MD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
Invited Lecturer -- Vlad Ratziu, MD, PhD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
Patient Perspective -- Maite Pujol
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
New Biomarkers in NAFLD -- Manuel Romero-Gomez, MD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
The ABC of viral hepatitis- Mark Thursz, MRCP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Burden of Liver Disease in North Africa- Ayman Yosry
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Clinical spectrum of liver disease in Africa- Wendy Spearman, MBChB, FCP, FRCP, MMed, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
The global challenge of viral hepatitis- Olufunmilayo Lesi, MD, MBA, FMCP, FWACP
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Hepatitis D - a forgotten foe?- Richard Njouom, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Hepatitis B stigma by association with HIV in Zambia- Michael Vinikoor
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Prevalence estimates of chronic hepatitis B virus infection: a comparative study of four sources and implications for burden assessment in sub-Saharan Africa- Nora Schmit
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Epidemiology of hepatitis B and evaluation of vaccine efficacy in a census-based community serosurvey of Ndirande township in Blantyre, Malawi- Alexander Stockdale
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Hepatitis B screening and prevention integration into ante-natal care and delivery services in an urban cohort in Mozambique- Natalia Tamayo Antabak
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Population-based evaluation of hepatitis B markers and criteria for antiviral therapy in Lusaka Province, Zambia- Michael Vinikoor
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Treatment of chronic hepatitis B in sub-Saharan Africa: 3-year results of a pilot program in Ethiopia- Asgeir Johannessen
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Characterization of Hepatitis B Virus (HBV) Among Liver Patients in Kenya- Missiani Ochwoto
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Prevalence of HBV and HCV infections in screened people in Rwanda during WHD 2017 campaign- Jean Damascene Makuza
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
HCV diagnosis and direct-acting antiviral agents -based treatment for HIV/HCV co-infected patients in a primary care setting in Maputo, Mozambique- Natalia Tamayo Antabak
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Ledipasvir/Sofosbuvir for Treatment of Hepatitis C Virus Infection in Rwanda: Results from the SHARED Trial- Emmanuel Musabeyezu
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018
Slidesets
Viral hepatitis in paediatrics (B and C)- Manal El-Sayed, MD, PhD
Presented at:
Conference on Liver Disease in Africa (COLDA) 2018